• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA(miR-221-3p、miR-133a-3p和miR-9-5p)在口腔黏膜下纤维化和鳞状细胞癌中的表达研究

Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma.

作者信息

Ukey Shweta, Jain Ankit, Dwivedi Shailendra, Choudhury Chinmayee, Vishnoi Jeewan Ram, Chugh Ankita, Purohit Purvi, Pareek Puneet, Elhence Poonam, Misra Sanjeev, Sharma Praveen

机构信息

All India Institute of Medical Sciences, Jodhpur, Rajasthan 342005 India.

All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh India.

出版信息

Indian J Clin Biochem. 2023 Jan;38(1):73-82. doi: 10.1007/s12291-022-01035-x. Epub 2022 Apr 29.

DOI:10.1007/s12291-022-01035-x
PMID:36684498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9852399/
Abstract

Oral squamous cell carcinoma (OSCC) is one of the common types of cancer. Its progression follows a transition from oral potentially malignant disorders (OPMDs) such as oral submucous fibrosis (OSMF). Epigenetic modifiers, especially microRNAs (miRNAs), have an appreciable role in the regulation of various carcinogenic pathways which are being used as biomarkers. miRNAs may also be helpful in the differentiation of oral submucous fibrosis from oral squamous cell carcinoma. Three miRNAs, miR-221-3p, miR133a-3p, and miR-9-5p, were found differentially expressed in many cancers in the literature search supported by our preliminary database search-based screening. The literature and our functional enrichment analysis in an earlier study have reported these miRNAs to regulate carcinogenesis at various steps. In the present study, the expression of these miRNAs was examined in 34 histopathologically confirmed OSCC, 30 OSMF, and 29 control (healthy volunteers) human samples. There was a significant downregulation of miRNA-133a-3p in OSCC compared to OSMF and controls, whereas there was up-regulation in oral submucous fibrosis compared to controls. There was no significant difference in the expression of miR-221-3p between OSCC and OSMF, but an upregulation in OSCC compared to controls. miR-9-5p was also found upregulated in both OSCC and OSMF. Further, miR-133a-3p expression was negatively correlated with age, smoking, drinking status, and AJCC staging, whereas miR-9-5p expression was only positively associated with tobacco/ areca nut chewing. The ROC plots, logistic regression model generated, and the correlation between the expression of miR-9-5p and miR-133a-3p in blood and tissue suggests that these could be used as risk stratification biomarkers.

摘要

口腔鳞状细胞癌(OSCC)是常见的癌症类型之一。其发展过程是从口腔潜在恶性疾病(OPMDs)如口腔黏膜下纤维化(OSMF)转变而来。表观遗传修饰因子,尤其是微小RNA(miRNAs),在调控各种致癌途径中发挥着重要作用,这些途径正被用作生物标志物。miRNAs在区分口腔黏膜下纤维化和口腔鳞状细胞癌方面也可能有所帮助。在我们基于初步数据库搜索的筛选支持下的文献检索中发现,三种miRNAs,即miR-221-3p、miR133a-3p和miR-9-5p,在许多癌症中差异表达。文献以及我们早期研究中的功能富集分析表明,这些miRNAs在致癌过程的各个步骤中发挥调控作用。在本研究中,检测了34例经组织病理学确诊的OSCC、30例OSMF和29例对照(健康志愿者)人体样本中这些miRNAs的表达。与OSMF和对照相比,OSCC中miRNA-133a-3p显著下调,而与对照相比,口腔黏膜下纤维化中miRNA-133a-3p上调。OSCC和OSMF之间miR-221-3p的表达无显著差异,但与对照相比,OSCC中miR-221-3p上调。miR-9-5p在OSCC和OSMF中均上调。此外,miR-133a-3p的表达与年龄、吸烟、饮酒状况和美国癌症联合委员会(AJCC)分期呈负相关,而miR-9-5p的表达仅与烟草/槟榔咀嚼呈正相关。ROC曲线、生成的逻辑回归模型以及血液和组织中miR-9-5p和miR-133a-3p表达之间的相关性表明,这些可作为风险分层生物标志物。

相似文献

1
Study of MicroRNA (miR-221-3p, miR-133a-3p, and miR-9-5p) Expressions in Oral Submucous Fibrosis and Squamous Cell Carcinoma.微小RNA(miR-221-3p、miR-133a-3p和miR-9-5p)在口腔黏膜下纤维化和鳞状细胞癌中的表达研究
Indian J Clin Biochem. 2023 Jan;38(1):73-82. doi: 10.1007/s12291-022-01035-x. Epub 2022 Apr 29.
2
Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC).口腔黏膜下纤维化(OSMF)和口腔鳞状细胞癌(OSCC)患者中hsa miR - 101 - 5p和hsa miR - 155 - 3p表达与c - Fos的相关性
J Maxillofac Oral Surg. 2023 Jun;22(2):381-387. doi: 10.1007/s12663-021-01668-0. Epub 2021 Nov 27.
3
Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.循环微小RNA-21表达作为口腔黏膜下纤维化和口腔鳞状细胞癌的新型血清生物标志物
Asian Pac J Cancer Prev. 2018 Apr 27;19(4):1053-1057. doi: 10.22034/APJCP.2018.19.4.1053.
4
Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.口腔黏膜下纤维性变相关口腔鳞状细胞癌的分子谱分析。
J Cancer Res Ther. 2022 Jan-Mar;18(1):55-65. doi: 10.4103/jcrt.JCRT_508_20.
5
Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma.口腔鳞状细胞癌患者肿瘤活检中miR-486-3p、miR-548-3p、miR-561-5p和miR-509-5p表达的评估
Pathogens. 2022 Feb 5;11(2):211. doi: 10.3390/pathogens11020211.
6
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.唾液细胞外囊泡相关 microRNA 作为口腔鳞状细胞癌潜在的生物标志物。
BMC Cancer. 2018 Apr 18;18(1):439. doi: 10.1186/s12885-018-4364-z.
7
Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.循环外泌体 microRNAs 在白斑、口腔黏膜下纤维化和白斑与口腔黏膜下纤维化合并病变中的表达谱。
Head Neck Pathol. 2024 Mar 27;18(1):28. doi: 10.1007/s12105-024-01627-4.
8
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.口腔黏膜下纤维性变背景下的口腔鳞状细胞癌是一种具有独特临床病理特征的疾病,其预后较好。
J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28.
9
MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.口腔鳞状细胞癌中的 microRNA 表达模式:hsa-mir-99b-3p 和 hsa-mir-100-5p 作为口腔癌的新型预后标志物。
Head Neck. 2019 Oct;41(10):3499-3515. doi: 10.1002/hed.25866. Epub 2019 Jul 29.
10
MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.miR-133a-3p 通过抑制 COL1A1 抑制口腔鳞状细胞癌(OSCC)的增殖和侵袭。
J Cell Biochem. 2018 Jan;119(1):338-346. doi: 10.1002/jcb.26182. Epub 2017 Jun 27.

引用本文的文献

1
Expression of SOX10, and micro-RNA 221 and Micro-RNA 222 in Oral Squamous Cell Carcinoma and Correlation with Clinicopathological Characteristics.SOX10、微小RNA 221和微小RNA 222在口腔鳞状细胞癌中的表达及其与临床病理特征的相关性
Head Neck Pathol. 2025 Jun 25;19(1):76. doi: 10.1007/s12105-025-01809-8.
2
The Use of Diagnostic Tumor Markers in Detecting Tobacco- and Betel Quid-Induced Oral Squamous Cell Carcinoma: A Scoping Review of Empirical Evidence.诊断性肿瘤标志物在检测烟草和槟榔诱导的口腔鳞状细胞癌中的应用:实证证据的范围综述
Health Sci Rep. 2025 Apr 18;8(4):e70650. doi: 10.1002/hsr2.70650. eCollection 2025 Apr.
3
Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.miRNA 及其相关基因的生物信息学分析,以鉴定口腔黏膜下纤维性变和口腔恶性肿瘤的潜在生物标志物。
Cancer Rep (Hoboken). 2023 Apr;6(4):e1787. doi: 10.1002/cnr2.1787. Epub 2023 Jan 28.
4
Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast Transition in Fibrosis.非编码 RNA:纤维化中纤维母细胞向肌成纤维细胞转化的主要调节因子。
Int J Mol Sci. 2023 Jan 16;24(2):1801. doi: 10.3390/ijms24021801.
5
Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy.卵巢癌患者化疗耐药背景下的临床及分子评估
Front Oncol. 2022 Aug 5;12:954008. doi: 10.3389/fonc.2022.954008. eCollection 2022.

本文引用的文献

1
MicroRNA-133 Targets in and Human Oral Cancer Cells to Regulate Epithelial-Mesenchymal Transition.微小RNA-133在人口腔癌细胞中的靶点以调节上皮-间质转化
J Cancer. 2021 Jul 3;12(17):5296-5309. doi: 10.7150/jca.56138. eCollection 2021.
2
Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4.miR-133b 的抑制表明预后不良,并通过 SOX4 促进 OSCC 的进展。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12717-12726. doi: 10.26355/eurrev_202012_24170.
3
Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.口腔潜在恶性疾病:世界卫生组织合作中心口腔癌会议召集的国际研讨会关于命名和分类的共识报告。
Oral Dis. 2021 Nov;27(8):1862-1880. doi: 10.1111/odi.13704. Epub 2020 Nov 26.
4
Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation.口腔黏膜下纤维性变中口腔黏膜干细胞标志物的丧失及其在恶性转化中的再激活。
Int J Oral Sci. 2020 Aug 21;12(1):23. doi: 10.1038/s41368-020-00090-5.
5
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity.HPV+HNSCC 来源的外泌体 miR-9 诱导巨噬细胞 M1 极化,增加肿瘤放射敏感性。
Cancer Lett. 2020 May 28;478:34-44. doi: 10.1016/j.canlet.2020.02.037. Epub 2020 Feb 29.
6
MicroRNA dysregulation and multi-targeted therapy for cancer treatment.miRNA 失调与癌症治疗的多靶点疗法。
Adv Biol Regul. 2020 Jan;75:100669. doi: 10.1016/j.jbior.2019.100669. Epub 2019 Oct 13.
7
Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy.口腔黏膜下纤维性变:病因发病机制、诊断及治疗的综述。
Int J Mol Sci. 2019 Jun 16;20(12):2940. doi: 10.3390/ijms20122940.
8
Regulation of by Antitumor Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma.抗肿瘤药物对[具体物质]的调控抑制肺鳞状细胞癌中癌细胞的侵袭性特征 。 (注:原文中by后面的内容缺失,这里翻译是基于补充完整后逻辑通顺的假设)
Cancers (Basel). 2019 Feb 22;11(2):258. doi: 10.3390/cancers11020258.
9
miR-9: From function to therapeutic potential in cancer.微小RNA-9:从功能到癌症治疗潜力
J Cell Physiol. 2019 Sep;234(9):14651-14665. doi: 10.1002/jcp.28210. Epub 2019 Jan 28.
10
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.